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Abstract: When pathologically externalized, phosphatidylethanolamine (PE) 
is a potential surrogate marker for detecting tissue injuries. 99mTc-labeled 
duramycin is a peptide-based imaging agent that binds PE with high affinity 
and specificity. The goal of the current study was to investigate the clearance 
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kinetics of 99mTc-labeled duramycin in a large animal model (normal pigs) and 
to assess its uptake in the heart using a pig model of myocardial ischemia–
reperfusion injury. 
Methods 
The clearance and distribution of intravenously injected 99mTc-duramycin were 
characterized in sham-operated animals (n = 5). In a closed chest model of 
myocardial ischemia, coronary occlusion was induced by balloon angioplasty 
(n = 9). 99mTc-duramycin (10–15 mCi) was injected intravenously at 1 hour 
after reperfusion. SPECT/CT was acquired at 1 and 3 hours after injection. 
Cardiac tissues were analyzed for changes associated with acute cellular 
injuries. Autoradiography and gamma counting were used to determine 
radioactivity uptake. For the remaining animals, 99mTc-tetrafosamin scan was 
performed on the second day to identify the infarct site. 
Results 
Intravenously injected 99mTc-duramycin cleared from circulation 
predominantly via the renal/urinary tract with an α-phase half-life of 
3.6 ± 0.3 minutes and β-phase half-life of 179.9 ± 64.7 minutes. In control 
animals, the ratios between normal heart and lung were 1.76 ± 0.21, 
1.66 ± 0.22, 1.50 ± 0.20 and 1.75 ± 0.31 at 0.5, 1, 2 and 3 hours post-
injection, respectively. The ratios between normal heart and liver were 
0.88 ± 0.13, 0.80 ± 0.13, 0.82 ± 0.19 and 0.88 ± 0.14. In vivo visualization 
of focal radioactivity uptake in the ischemic heart was attainable as early as 
30 min post-injection. The in vivo ischemic-to-normal uptake ratios were 
3.57 ± 0.74 and 3.69 ± 0.91 at 1 and 3 hours post-injection, respectively. 
Ischemic-to-lung ratios were 4.89 ± 0.85 and 4.93 ± 0.57; and ischemic-to-
liver ratios were 2.05 ± 0.30 to 3.23 ± 0.78. The size of 99mTc-duramycin 
positive myocardium was qualitatively larger than the infarct size delineated 
by the perfusion defect in 99mTc-tetrafosmin uptake. This was consistent with 
findings from tissue analysis and autoradiography. 
Conclusion 
99mTc-duramycin was demonstrated, in a large animal model, to have suitable 
clearance and biodistribution profiles for imaging. The agent has an avid 
target uptake and a fast background clearance. It is appropriate for imaging 
myocardial injury induced by ischemia/reperfusion. 
Keywords: Duramycin; Phosphatidylethanolamine; Ischemia–reperfusion 
injury; Apoptosis 
1. Introduction 
In mammalian cells, the phospholipid bilayer of the plasma 
membrane serves as a physical barrier with important biological 
functions. The pathological disruption of the bilayer can result in a 
scrambled phospholipid distribution with or without membrane 
rupturing.1,2 The exposure of aminophospholipids such as 
phosphatidylserine (PS) and phosphatidylethanolamine (PE) provides 
surrogate markers for detecting tissue injuries. Imaging strategies that 
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target scrambled phospholipid bilayer in various tissues have been 
widely reported.2,3,4,5,6 
There has been a continuous effort to develop positive 
radionuclide imaging techniques for detecting ischemic injury in the 
cardiovascular system.7 This effort is geared toward a combination of 
robust molecular recognition mechanism, an avid target uptake, and a 
rapid blood clearance (preferably renal) with a low blood pool and 
hepatic background. These criteria are critical for cardiac imaging 
applications, because of large bodies of blood pool from adjacent heart 
cambers and close vicinity to the liver especially at the apical region of 
the heart. Additionally, like most diagnostic imaging procedures, it is 
desirable to perform the scan in a timely fashion, preferably shortly 
after tracer injection without a prolonged delay. In this regard, the 
lantibiotic duramycin is uniquely situated because of its structural 
features. Duramycin is currently the smallest known polypeptide that 
forms a stereospecific binding pocket.8,9 It has receptor-like binding 
behaviors, yet peptide-like clearance kinetics.10,11 Duramycin binds PE 
with a high affinity with a Kd reported at around 5 nM.12 It was also 
reported that once bound to PE, the binding does not readily dissociate 
even in the presence of organic solvent.12 A combination of tight 
binding with low molecular weight makes duramycin a candidate of 
interest for cardiovascular imaging applications. 
The aims of the current study were to evaluate the clearance of 
intravenously injected 99mTc-duramycin in healthy pigs and to test the 
feasibility of detecting acute myocardial injury in a porcine model of 
coronary occlusion/reperfusion. The sarcolemma of cardiomyocytes is 
a rich source of PE, which when exposed at the extracellular surface 
provides stereospecific and abundant binding targets in conditions 
such as ischemic injuries.13 In this work, we present results of studies 
with 99mTc-duramycin in a porcine model of ischemia. Since the porcine 
cardiovascular system is comparable to that of humans, these studies 
provide important data for assessing 99mTc-duramycin as an effective 
imaging agent for detecting ischemic injuries in the heart. 
2. Materials and methods 
Duramycin was covalently modified with succinimidyl 6-
hydrazinonicotinate acetone hydrazone (HYNIC, Solulink) and purified 
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by HPLC as previously reported.10 The molecular weight of HYNIC 
modified duramycin was confirmed using matrix-assisted laser 
desorption/ionization mass spectrometry. The radiopharmaceutical was 
prepared using a single-step kit formulation, where 740–925 MBq (20–
25 mCi) technetium-99 m was injected into duramycin kit vial and 
heated for 20 min at 80 °C. Quality control steps, including radioHPLC 
and stability tests, were carried out as described before.11,14 
2.1. Clearance studies in normal animals 
The animal protocol was approved by the Institutional Animal 
Care and Use Committee at Nanjing First Hospital affiliated to Nanjing 
Medical University and at the Feinberg School of Medicine, 
Northwestern University. For characterizing the clearance and 
distribution profiles of 99mTc-duramycin, five control animals were 
studied. Pigs (M/F, 25–30 kg) were initially anesthetized with 
intramuscular injection of ketamine hydrochloride (10 mg/kg). 
Anesthesia was maintained using isoflurane. A balloon catheter (length 
15 mm, diameter 2.5–3 mm) was delivered into the coronary branches 
then withdrawn without inflation as sham operated control. A dose of 
99mTc-duramycin (370–555 MBq, 10–15 mCi/animal) was injected into 
the ear vein. Blood samples were withdrawn for gamma counting 
measurements at 0.5, 1, 2, 3, 4, 5, 10, 15, 30, 60, 120 and 
180 minutes post-injection. Anterior whole-body planar and SPECT/CT 
images were acquired at 0.5, 1, 2 and 3 hr post-injection using a 
Symbia TruePoint hybrid SPECT/CT scanner (Siemens). The 
parameters for planar imaging were 140 ± 20% keV energy window, 
128 x 128 matrix size, 1 million total counts. Parameters for SPECT 
included 140 ± 20% keV, with 6 sec acquisition per projection angle. 
CT was used for attenuation correction and anatomical coregistration 
with SPECT images. Based on blood sample gamma counting 
measurements, the biphasic clearance time–activity data were fit to 
the following two-exponential equation: 
Cb(t) = Ae − t/α + (100 − A)e − t/β 
 
where A and (100 − A) are the factional (%) amplitudes of the two 
exponentials with a fast time constant α (fast phase) and a slow time 
constant β (slow phase), respectively. The half-lives of the α and β 
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phases were then determined by scaling the estimated corresponding 
time constants by ln(2). 
2.2. Imaging myocardial injury in a porcine model of 
coronary occlusion and reperfusion 
For the coronary occlusion group, pigs (n = 9, M/F, 25–30 kg) 
were anesthetized as described above. A balloon catheter (length 
15 mm, diameter 2.5–3 mm) was positioned into one of the following 
coronary branches: distal end of the left descending coronary artery 
(n = 5), or left circumflex branch (n = 4). Arterial occlusion was 
initiated by inflating and maintaining the angioplasty balloon at 
8 atmosphere pressure and lasted between 20 and 30 min. 
Reperfusion was initiated by deflating and withdrawal of the 
angioplasty balloon. Both coronary occlusion and the subsequent 
reperfusion were confirmed by angiography. ECG profiles typical of 
acute ischemic and reperfusion injury, including arrhythmia and ST 
segment depression or elevation, were observed. Levels of cardiac 
enzymes, including creatine kinase (CK) and creatine kinase MB 
(CKMB), were measured for validation of acute myocardial injury. At 
1 hr after reperfusion, 370–555 MBq (10–15 mCi/animal) of 99mTc-
duramycin was injected into the ear vein, anterior whole-body planar 
images were acquired at 0.5 hour post-injection. SPECT/CT images 
were acquired at 1 and 3 hr post-injection. Perfusion imaging was 
performed on the second day, at 45 min after an intravenous injection 
of 99mTc-tetrofosmin (370–555 MBq, 10–15 mCi/animal). Imaging data 
were reconstructed and processed with attenuation correction based 
on the acquired CT data using software provided by the manufacturer 
(Syngo, Siemens). SPECT data localization was validated using CT 
anatomical coregistration. Radioactivity uptake in regions of interests 
was determine at 1 and 3 hours post-injection for the myocardial wall, 
lung and liver in terms of counts/voxel/min. Uptake ratios between 
heart/lung and heart/liver were subsequently calculated. 
2.3. Tissue analysis 
Representative cardiac tissue specimens were harvested from 
the ischemic core and periphery for analysis. To quantitatively 
examine the extent of DNA damage of each cell, we performed flow 
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cytometric analysis on cardiac cells isolated from separate tissue 
specimens. Cardiac tissues were dissected into small pieces, and were 
gently pressed through a fine mesh. The cells were fixed, stained with 
Propidium Iodide and analyzed by flow cytometry. The presence of 
cells with sub-G0 DNA content was determined. This procedure was 
performed in 3 independent measurements using tissues from 3 
different animals. Hematoxylin and eosin (H&E) staining was 
performed on cryosections. For ultrastructural examination, ultrathin 
sections were cut from core ischemic tissues on an Ultracut 
ultramicrotome (Mager Scientific Inc., Dexter, MI), mounted on mesh 
copper grids, and poststained in uranyl acetate and Reynold's lead 
citrate. The sections were examined using a transmission electronic 
microscope (JEM-1010). The presence of apoptosis was determined 
using tissues harvested from the periphery of ischemic regions. DNA 
fragmentation was analyzed by terminal deoxynucleotidytransferase 
mediated dUTP nick-end labeling (TUNEL) assay using a commercial kit 
(Maxin-Bio) according the manufacturer's protocol on 8 μm 
cryosections. TUNEL-positive nuclei as a percentage of total nuclei was 
determined and used as the apoptotic index. 
2.4. Statistical analysis 
All data were expressed as mean ± standard deviation; 
statistical analysis was performed using Student's t-test, where a P 
value of less than 0.05 was considered statistically significant. 
3. Results 
3.1. In vivo kinetic studies in normal pigs 
The radiopharmaceutical dose consistently had a radiochemical 
purity at 90% or greater, and was stable without significant presence 
of dissociated radioactivity. After intravenous injection, 99mTc-
duramycin cleared from the blood circulation with predominantly renal 
excretion, leaving a low systemic background including the blood pool 
and liver. The blood clearance profile of 99mTc-duramycin in control 
animals is shown in Fig. 1A. The half-life for the fast clearance phase 
(α-phase), which accounted for 77.6% ± 5.5% of blood activity, was 
estimated to be 3.6 ± 0.3 minutes (n = 5). The half-life for the slow 
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clearance phase (β-phase) was estimated to be 179.9 ± 64.7 minutes 
(n = 5). According to the SPECT data, the radioactivity uptake levels in 
terms of counts/voxel/min in normal heart, lung and liver, and their 
dynamic clearance profiles are shown in Fig. 1B. The ratios between 
normal heart and lung were 1.76 ± 0.21, 1.66 ± 0.22, 1.50 ± 0.20 
and 1.75 ± 0.31 at 0.5, 1, 2 and 3 hours post-injection, respectively. 
The ratios between normal heart and liver were 0.88 ± 0.13, 
0.80 ± 0.13, 0.82 ± 0.19 and 0.88 ± 0.14. Representative whole-body 
anterior planar images acquired at 0.5, 1, 2 and 3 hours post-injection 
are shown in Fig. 1C. The time series of planar images are presented 
with the same threshold and scale bar. Apart from the bladder signal, 
the cardiac blood pool and liver background was visible at 30 minutes 
after 99mTc-duramycin injection. These signals diminished over time to 
near background levels. 
 
Fig. 1. 99mTc-duramycin clearance and distribution in control animals. (A) Blood 
clearance profile as a function of time. Solid line: two-exponential fitting for estimation 
of blood clearance half-lives. (B) Organ clearance profiles derived from serial SPECT 
data, for the heart (○), lung (■) and liver (▲) as a function of time. (C) Serial anterior 
whole-body planar images acquired at 30, 60, 120 and 180 minutes after intravenous 
99mTc-duramycin injection. 
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3.2. In vivo imaging in a porcine model of myocardial 
ischemia and reperfusion 
In animals that experienced myocardial ischemia and 
reperfusion, the presence of tissue injuries was confirmed by cardiac 
enzyme tests. CK level elevated from 310.3 ± 23.2 to 
1793.4 ± 1451.6 (P = 0.045), and CKMB level increased from 
44.0 ± 5.4 to 661.2 ± 281.3 (P < 0.01). Focal uptake at the ischemic 
site was clearly discernible in planar whole-body scans as early as 
30 minutes after injection (Fig. 2A). In contrast, this was absent in 
control animals but only a diffused blood pool background (Fig. 1C). In 
SPECT images acquired at 1 hour post-injection, a prominent hot spot 
at the ischemic myocardium in the anterior left free wall was 
detectable, as seen in representative images (Fig. 2B and C). 
Radioactivity uptake in the remote, normal myocardium was at 
background. Signals from the blood pool in heart chambers were 
minimal. At 3 hours post-injection, the focal uptake remained 
conspicuous without washout (Fig. 3A and B). In 99mTc-tetrafosamin 
scan acquired on day 2 the perfusion deficiency was found at the same 
location as the 99mTc-duramycin hotspot, but appeared to be smaller in 
size upon visual inspection of the images (Fig. 3C and D). Of the 9 
animals enrolled, 5 had myocardial ischemia in the left anterior 
coronary branch, and the remaining 4 had occlusion at the circumflex 
territory. Hot spot radioactivity uptake unambiguously identified all 
ischemic regions. An additional example, taken at 1 hr post-injection 
from an animal with a relatively small region of myocardial ischemia at 
the distal region in the circumflex territory, is shown in Fig. 4. Overall, 
signals at the focal uptake in ischemic regions were significantly above 
background. The ischemic-to-remote uptake ratios were 3.57 ± 0.74 
and 3.69 ± 0.91 at 1 and 3 hours post-injection, respectively. 
Ischemic-to-lung ratios were 4.89 ± 0.85 and 4.93 ± 0.57, at 1 and 
3 hours, respectively. Over the same period, there was a significant 
improvement in ischemic-to-liver ratios, from 2.05 ± 0.30 to 
3.23 ± 0.78 (P < 0.05). No adverse effect associated with the injected 
radiopharmaceutical was seen. 
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Fig. 2. Imaging ischemic myocardial injury using 99mTc-duramycin in a pig model of 
myocardial ischemia and reperfusion. (A) Whole-body anterior planar image acquired 
at 30 minutes post-injection. Radioactivity uptake in the ischemic heart region can be 
differentiated from the background, as marked by an arrow. Injection site via the ear 
vein is marked with an asterisk. Left and right kidneys are labeled as KL and KR, 
respectively. The bladder is marked as BL. (B and C) Short- and long-axial SPECT/CT 
fusion images acquired at 1 hour post-injection, with a hot spot 99mTc-duramycin 
uptake at the anterior left ventricular free wall (arrow). (D and E) Short- and long-
axial images acquired at 3 hours from the same animal. Consecutive slices are shown 
in Supplementary Fig. 1 and Supplementary Fig. 2, for 1 and 3 hour data, 
respectively. 
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Fig. 3. A representative example of a relatively small, apical region of ischemic injury 
detected in SPECT/CT using 99mTc-duramycin. (A) Short-axial CT of the thorax. (B and 
C) A small area of ischemic and reperfusion injury was identified (arrows) at the apical 
region of the heart as a result of distal circumflex occlusion. 
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Fig. 4. Imaging small region of acute ischemic myocardial injury using 99mTc-
duramycin. (A) Short-axial CT of the thorax. (B and C) A small area of ischemic and 
reperfusion damage is identified (arrows) at the apical region of the heart as a result 
of distal circumflex occlusion. 
3.3. Post-mortem tissue analysis 
The localization of radioactivity uptake in ischemic tissue was 
examined in post-mortem analysis. As shown in Fig. 5A, the location of 
hot spot radioactivity uptake was consistent with the perfusion 
territory of occluded coronary branch. The presence of high 
radioactivity was localized at TTC-deficient, infarcted myocardium as 
well as border regions. The total area positive for radioactivity was 
visually larger than the size of total infarcted (TTC-negative) tissues. 
These measurements were consistent with visibly larger 99mTc-
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duramycin-positive regions in vivo versus perfusion defects in 99mTc-
tetrofosmin scan. The percentage of nuclei with DNA damage 
characteristic of apoptotic cells in ischemic myocardium, as shown by 
TUNEL assay (Fig. 5B), was 28.04% ± 3.25% versus a baseline of 
3.49% ± 1.83% in normal myocardium (P < 0.001). This was 
accompanied with a rise in cells at sub-G0 phase (4.62% ± 1.96% 
versus 0.50% ± 0.23% in normal myocardium, P = 0.022), which 
reflects necrotic cells that had reduced nucleic acid content due to 
compromised plasma membrane and cellular integrity. The relatively 
high percentage of apoptotic and necrotic cells was consistent with 
ischemic/reperfusion injury. Ultrastructural changes associated with 
ischemic tissue damages were documented using transmission electron 
microscopy, where features that are typical of apoptotic and necrotic 
cell death are present, including cytoplasm shrinkage, nuclear 
condensation and marginalization, and mitochondrial deformation 
(Fig. 5C). The presence of fragmented nuclei, myofibril degeneration 
and local hemorrhage, which are typical changes associated with 
ischemic injuries, are detected in H&E stained tissue sections 
(Fig. 5D). 
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Fig. 5. Histological analyses. (A) TTC stained (upper) and autoradiography (lower) of 
the same short-axial heart sections. (B) TUNEL staining of tissue harvested from the 
periphery of the ischemic core. (C) Ultrastructural changes associated with 
ischemia/reperfusion injury, as identified with transmission electron microscopy. (D) 
H&E staining of damaged myocardium at the ischemic zone. 
4. Discussion 
There are a number of significant findings from the current 
investigation. As demonstrated in a large animal model, the in vivo 
clearance profile of 99mTc-duramycin is appropriate for imaging in the 
cardiovascular system. An avid uptake in the target tissue combined 
with a low background enabled the noninvasive imaging of 
ischemic/reperfusion myocardial injury in the acute phase as early as 
30 minutes after injection. In addition to an uptake in infarcted 
myocardium, 99mTc-duramycin binding to ischemic-but-noninfarct 
tissues indicated that it was effective in detecting ischemically injured 
myocardium. 
Molecular features of 99mTc-duramycin are unique for having 
both a robust binding mechanism and a favorable clearance profile. 
Antibodies and larger proteins have exquisite binding properties but 
suboptimal clearance for in vivo imaging. On the other hand, while 
short peptides in general have superior pharmacokinetics, they lack 
structurally-defined binding modules such as that of immunoglobulin 
fold. The underlying conundrum is that a strong molecular recognition 
mechanism requires a well-defined binding structure, which often 
necessitates extensive scaffolding only afforded in large proteins. 
Currently, the roles of peptide-based imaging agents are 
predominantly confined to ligands that are recognized and sequestered 
by cognate receptors. The molecular features of duramycin combine 
the two extremes in the spectrum of binding-versus-size relationship. 
The overall structure of duramycin with a stereospecific binding pocket 
is accomplished with only 19 amino acids (molecular weight 2 kDa), 
making duramycin and its structural derivatives uniquely situated for 
imaging applications. 
With accumulating evidence, the pathological externalization of 
PE is being established as an imaging marker for tissue/cellular 
injuries.10,11,15,16,17 The sarcolemma of cardiomyocytes is a rich source 
of PE, which when externalized to the cell surface constitutes an 
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abundant molecular target. In contrast to conventional infarct-avid 
imaging approaches, membrane phospholipid scrambling occurs in 
both apoptosis and necrosis. In cells under severe ischemia, their 
ability to maintain proper phospholipid asymmetry is compromised, 
and the transbilayer redistribution of aminophospholipids provides an 
additional source of target for detection.18,13,19 As such, membrane 
phospholipid scrambling as a biomarker reflects global injury instead of 
infarction per se. This was consistent with the current finding where 
the myocardial region positive for 99mTc-duramycin uptake was visually 
more expansive than the infarct alone. When fully established, the 
ability to accurately assess the full extent of myocardial injury is likely 
to lead to a better diagnostic marker for ischemic coronary syndromes, 
with prognostic predictive value for adverse cardiac events like heart 
failure and the risk for arrhythmia. 
5. Conclusion 
The clearance of intravenously injected 99mTc-duramycin was 
predominantly via the renal/urinary tract with relatively low systemic 
and hepatic background in a large animal model. These in vivo 
properties were suitable for imaging applications for the cardiovascular 
system. Data from the porcine model of myocardial ischemia and 
reperfusion indicated that the uptake of 99mTc-duramycin enabled the 
detection of ischemically-injured myocardial tissues effectively. 
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The following are the supplementary data related to this article. 
Supplementary Fig. 1.   
 
Consecutive slices in axial, sagittal and coronal SPECT/CT data acquired at 1 hr post 
injection. 
  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Nuclear Medicine and Biology, Vol 41, No. 2 (February 2015): pg. 198-204. DOI. This article is © Elsevier and permission 
has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this 
article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
19 
 
Supplementary Fig. 2.   
 
Consecutive slices in axial, sagittal and coronal SPECT/CT data acquired at 
3 hr post injection. 
 
